InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (6 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
6
T+90 hit rate
100%
T+90 mean return
+74.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Boyd Peter E., See Remarks. Insider active across 1 company, notably Aquestive Therapeutics, Inc.. Cumulatively, 12 disclosures have been published. Split: 2 buys · 6 sells. Total volume traded: €371k. History available since 8 June 2022. The latest transaction was filed on 15 October 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
10,000 shares@ US$7.0016.2% of flowCommon StockSEC:0001214659-25-015046
10,000 shares@ US$7.000.0076% mcap16.2% of flowCommon StockSEC:0001214659-25-015046:0
10,000 shares@ US$6.300.0069% mcap14.6% of flowCommon StockSEC:0001214659-25-014287:0
10,000 shares@ US$6.3014.6% of flowCommon StockSEC:0001214659-25-014287
15,000 shares@ US$5.3018.4% of flowCommon StockSEC:0001214659-25-013485
15,000 shares@ US$5.300.0087% mcap18.4% of flowCommon StockSEC:0001214659-25-013485:0
80,000 shares0Common StockSEC:0001214659-25-004222:0
8,370 shares@ US$4.889.1% of flowCommon StockSEC:0001214659-24-004394:0
86,250 shares0Common StockSEC:0001214659-24-004303:0
100,000 shares0Common StockSEC:0001214659-23-003695:0
5,000 shares@ US$0.810.0005% mcap1.0% of flowCommon StockSEC:0001628280-22-017186:0
Ideal exit: 11 Mar 2023 (T+270)
2,293 shares@ US$0.960.0003% mcap0.6% of flowCommon StockSEC:0001628280-22-016872:0
Ideal exit: 5 Mar 2023 (T+270)
12 of 12 declarations
About Boyd Peter E.
Boyd Peter E. is the SVP of Business Process and Information Technology at Aquestive Therapeutics, Inc. Although his role is classified as 'See Remarks', he is involved in essential functions that support the company's operations and enhance organizational efficiency.
